Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

En kulturelt tilpasset beslutningsstøtteintervensjon for å støtte kinesisk-amerikanske demensomsorgspersoner i beslutninger relatert til ernæring

31. oktober 2026 oppdatert av: Yaolin Pei

En kulturelt tilpasset beslutningsstøtteintervensjon for å støtte kinesisk-amerikanske demensomsorgsgivere i beslutninger knyttet til ernæring

Family caregivers of people with dementia have to decide between tube feeding and hand feeding when persistent eating problems arise. This decision can be difficult for Chinese American dementia caregivers, due to the interplay of culture, potential absence of a patient's advance directive, poor understanding of dementia, and lack of knowledge on the risks and benefits of tube feeding. In this polit study, the principal investigator examines whether a culturally adapted decision aid intervention regarding feeding options named "Chinese version of Making Choices Feeding Options for Patients with Dementia Decision Aid" (CMCFODA) will improve Chinese American caregivers' decision-making about feeding options in patients with moderate or advanced dementia. The proposed study advances the field by providing critical evidence to inform the development and implementation of culturally adapted decision support interventions in end-of-life dementia care.

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

60

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

21 år til 99 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Age 21 years and older
  • Self-identify as Chinese
  • Providing caregiving or involvement in end-of-life care decision-making for older Chinese adults with: a) moderate or advanced dementia, b) feeding difficulties, and c) poor oral intake, eating/swallowing problems, or weight loss

Exclusion Criteria:

  • Dementia patients are a) receiving tube feeding, b) enrolled in hospice care, or 3) have a documented preference against a feeding tube

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Ingen inngripen: Participation Group
  1. Receive usual care (including information from healthcare providers)
  2. Receive electrical version of decision aid after all of the data collection
Eksperimentell: Intervention/Treatment Group
  1. Receive both the electronic and paper version of CMCFODA
  2. Receive an individualized decision coaching within two weeks

Participants in the treatment group will receive the CMCFODA via zoom meeting or another secure video conferencing platform and an individualized decision coaching.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Decision conflict
Tidsramme: Baseline; One-Month Follow-Up; Three-Month Follow-Up

SURE test for decisional conflict (0-4)

Baseline; One-Month Follow-Up; Three-Month Follow-Up
Knowledge of feeding options and dementia
Tidsramme: Baseline; One-Month Follow-Up; Three-Month Follow-Up

Questions to assess knowledge about feeding options and dementia

Baseline; One-Month Follow-Up; Three-Month Follow-Up
Expectations of tube feeding
Tidsramme: Baseline; One-Month Follow-Up; Three-Month Follow-Up

Questions about understanding differing expectations regarding feeding tube use

Baseline; One-Month Follow-Up; Three-Month Follow-Up

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Frequency of communication with other family members and healthcare providers
Tidsramme: Baseline; One-Month Follow-Up; Three-Month Follow-Up

Questions to understand caregiver involvement, support, and information flow

Baseline; One-Month Follow-Up; Three-Month Follow-Up
Preference of feeding option
Tidsramme: Baseline; One-Month Follow-Up; Three-Month Follow-Up

Careful hand feeding, tube feeding, or unsure

Baseline; One-Month Follow-Up; Three-Month Follow-Up
Preparation for decision-making scale (treatment group only)
Tidsramme: One-Month Follow-Up; Three-Month Follow-Up

Questions to assess the effect of the intervention by preparing for feeding option decision-making

One-Month Follow-Up; Three-Month Follow-Up
The Feasibility of the CMCFODA study as measured by recruitment rates and the proportion of participants that decline participation.
Tidsramme: Enrollment

The feasibility of the CMCFODA study will be measured by the proportion of eligible participants who decline to participate among those who were screened into the study.

Enrollment
The Feasibility of the CMCFODA study as measured by participant retention, as indicated by the number of participants lost to follow-up.
Tidsramme: Enrollment, One-Month Follow-Up,Three-Month Follow-Up

Participant retention, as an aspect of feasibility, will be measured by the recorded number of participants number lost to follow-up.

Enrollment, One-Month Follow-Up,Three-Month Follow-Up
Acceptability of the decision aid and decision coaching (only for the treatment group)
Tidsramme: One Month Follow-Up

We will use developed questions to measure the acceptability of this intervention

One Month Follow-Up

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

24. mars 2026

Primær fullføring (Antatt)

31. juli 2027

Studiet fullført (Antatt)

31. juli 2028

Datoer for studieregistrering

Først innsendt

22. januar 2026

Først innsendt som oppfylte QC-kriteriene

26. januar 2026

Først lagt ut (Faktiske)

27. januar 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

4. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

31. oktober 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • STUDY00007171

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Data collected for the CMCFODA study will be shared only after the investigators have published findings addressing the study's specific aims. Intellectual property and data generated under this project will be managed in accordance with University of Texas at Austin and NIH policies, including the NIH Data Sharing Policy and Implementation Guidance. Following publication of the investigators' primary findings, access to the study databases and associated decision aid intervention tools will be made available for educational, research, and non-profit purposes.

IPD-delingstidsramme

These data will be shared after the investigators have published the study's specific aims. Requests to access the code for this study will be reviewed by the investigative team and granted once feasibility, acceptability, and preliminary efficacy have been evaluated and the findings have been published.

Tilgangskriterier for IPD-deling

Individuals who wish to access the data must agree to: (1) use the data solely for research purposes; (2) not attempt to identify any individual participant; (3) securely store the data using appropriate safeguards, such as password-protected servers and files; and (4) return and/or destroy the data upon completion of analyses.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • SEVJE
  • ICF
  • ANALYTIC_CODE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere